Aim: To describe our surgical technique for dissecting the apex of prostate during robotic-assisted laparoscopic radical prostatectomy (RALP) and detailed surgical anatomy of prostate including relationship between urethra and dorsal vein complex with apex. Materials and Methods: In retrospective view of prospective collected data, 73 patients underwent RALP between December 2012 and September 2014. Surgical anatomy of prostate was revealed in all procedures. Quality of life (QoL) scores were assessed before, immediately after catheter removal, and 1 month after surgery. We divided urinary continence into 3 groups, as very early continence; continence at time of urethral catheter removal, early continent; and continence 1 month after surgery. The rest of the patients were accepted as continence. Results: The mean follow-up was 10.2 ± 5.4 months and mean age was 61.5 ± 6.6. Maximum protection of urethra could be provided in all. Mean catheter removal was 8.9 ± 1.7 days, and all patients were continent at the time of catheter removal. QoL scores before RALP could be protected after surgery (p = 0.2). Neither conversion to open/conventional laparoscopic surgery nor complications related with bladder neck were detected. Conclusions: Our surgical technique can be a strong candidate for being a surgical technique for preserving urethra and very early continence could be provided after surgery.

Keywords:
Surgery, Urethra, Urinary continence, Prostate cancer, Robotics, Operative surgical procedure
1.
Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F; European Association of Urology: EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71.
2.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group: Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34.
3.
Bianco FJ Jr, Scardino PT, Eastham JA: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (‘trifecta'). Urology 2005;66(5 suppl):83-94.
4.
Merseburger AS, Herrmann TR, Shariat SF, Kyriazis I, Nagele U, Traxer O, Liatsikos EN; European Association of Urology: EAU guidelines on robotic and single-site surgery in urology. Eur Urol 2013;64:277-291.
5.
Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P: Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol 2012;62:1-15.
6.
Tunc L, Gumustas H, Akin Y, Atkin S, Peker T, Erdem O, Bozkirli I: A novel surgical technique for preserving the bladder neck during robotic-assisted laparoscopic radical prostatectomy: preliminary results. J Endourol 2015;29:186-191.
7.
Valdivieso RF, Hueber PA, Zorn KC: Robot assisted radical prostatectomy: how I do it. Part II: surgical technique. Can J Urol 2013;20:7073-7078.
8.
Hakimi AA, Faleck DM, Agalliu I, Rozenblit AM, Chernyak V, Ghavamian R: Preoperative and intraoperative measurements of urethral length as predictors of continence after robot-assisted radical prostatectomy. J Endourol 2011;25:1025-1030.
9.
Zugor V, Labanaris AP, Porres D, Witt JH: Surgical, oncologic, and short-term functional outcomes in patients undergoing robot-assisted prostatectomy after previous transurethral resection of the prostate. J Endourol 2012;26:515-519.
10.
D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH: Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21:2163-2172.
11.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
12.
van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B; ISUP Prostate Cancer Group: International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011;24:16-25.
13.
Cetinel B, Ozkan B, Can G: Validation study of ICIQ-SF. Turk J Urol 2004;30:339-347.
14.
SF-12® Health Survey Scoring Demonstration. http://www.sf-36.org/demos/SF-12.html (accessed November 2, 2015).
15.
The Visible Human Project Tools for Use with the Visible Human Data Set. http://www.nlm.nih.gov/research/visible/tools.html (accessed November 2, 2015).
16.
Gözen AS, Akin Y, Akgul M, Yazici C, Klein J, Rassweiler J: A novel practical trocar placement technique for extraperitoneal laparoscopic and robotic-assisted laparoscopic radical prostatectomy in patients with lower midline abdominal incisions. J Laparoendosc Adv Surg Tech A 2014;24:417-421.
17.
Vora AA, Dajani D, Lynch JH, Kowalczyk KJ: Anatomic and technical considerations for optimizing recovery of urinary function during robotic-assisted radical prostatectomy. Curr Opin Urol 2013;23:78-87.
18.
Hamada A, Razdan S, Etafy MH, Fagin R, Razdan S: Early return of continence in patients undergoing robot-assisted laparoscopic prostatectomy using modified maximal urethral length preservation technique. J Endourol 2014;28:930-938.
19.
Paparel P, Akin O, Sandhu JS, Otero JR, Serio AM, Scardino PT, Hricak H, Guillonneau B: Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging. Eur Urol 2009;55:629-637.
20.
Freire MP, Weinberg AC, Lei Y, Soukup JR, Lipsitz SR, Prasad SM, Korkes F, Lin T, Hu JC: Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol 2009;56:972-980.
21.
Kessler TM, Burkhard FC, Studer UE: Nerve-sparing open radical retropubic prostatectomy. Eur Urol 2007;51:90-97.
22.
Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, Menon M, Montorsi F, Myers RP, Rocco B, Villers A: A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 2010;57:179-192.
23.
Brien JC, Barone B, Fabrizio M, Given R: Posterior reconstruction before vesicourethral anastomosis in patients undergoing robot-assisted laparoscopic prostatectomy leads to earlier return to baseline continence. J Endourol 2011;25:441-445.
24.
Kravchick S, Lobik L, Peled R, Cytron S: Transrectal ultrasonography-guided injection of long-acting steroids in the treatment of recurrent/resistant anastomotic stenosis after radical prostatectomy. J Endourol 2013;27:875-879.
25.
Menon M, Hemal AK, Tewari A, Shrivastava A, Bhandari A: The technique of apical dissection of the prostate and urethrovesical anastomosis in robotic radical prostatectomy. BJU Int 2004;93:715-719.
26.
Hemal AK, Bhandari A, Tewari A, Menon M: The window sign: an aid in laparoscopic and robotic radical prostatectomy. Int Urol Nephrol 2005;37:73-77.
27.
Sood A, Jeong W, Peabody JO, Hemal AK, Menon M: Robot-assisted radical prostatectomy: inching toward gold standard. Urol Clin North Am 2014;41:473-484.
28.
Takenaka A, Tewari AK: Anatomical basis for carrying out a state-of-the-art radical prostatectomy. Int J Urol 2012;19:7-19.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.